Stocks making big moves this week: Qualcomm, Accenture, 10x Genomics, Seagate, and Lattice Semiconductor
10x Genomics (TXG): Buy, Sell, or Hold Post Q1 Earnings?
Collaboration aims to identify biomarkers predictive of antibody-drug conjugate (ADC) treatment response using 10x's single cell and spatial platforms
3 Small-Cap Stocks with Questionable Fundamentals
Acquisition Expands 10x Genomics' Capabilities in Proteomics
The 5 Most Interesting Analyst Questions From 10x Genomics’s Q1 Earnings Call
1 Cash-Producing Stock on Our Watchlist and 2 We Question
10x Genomics (NASDAQ:TXG) reported a first-quarter revenue increase excluding prior-year settlement revenue and used its earnings call to emphasize the launch of Atera, a new spatial biology instrument...
Why 10x Genomics (TXG) Stock Is Down Today
TXG Q1 Deep Dive: Atara Launch, Spatial Platform Transition, and AI-Driven Demand